Drug interactions
Caplacizumab + Dipyridamole
Severity: Moderate
Caplacizumab and Dipyridamole: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs impair platelet function, and their combination may increase bleeding risk. Dipyridamole has a weaker antiplatelet effect than many agents, but caution is warranted with caplacizumab.
What this interaction means in plain words
Caplacizumab and Dipyridamole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Caplacizumab belongs to Cardiovascular; Dipyridamole belongs to Cardiovascular.
Why it happens
Additive effects on platelet function: vWF-platelet binding blockade with dipyridamole's inhibition of platelet aggregation.
What to do
Monitor for bleeding, and consider withholding dipyridamole if bleeding occurs during caplacizumab therapy.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Caplacizumab and Dipyridamole, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dipyridamole
- Dipyridamole + Riociguat Contraindicated
- Adenosine + Dipyridamole Major
- Betrixaban + Dipyridamole Major
- Dabigatran + Dipyridamole Major
- Dipyridamole + Regadenoson Major
- Dipyridamole + Venetoclax Major
Other interactions of Caplacizumab
Frequently asked questions
Can I take Caplacizumab with Dipyridamole?
MediHelp rates the interaction as moderate. Caplacizumab and Dipyridamole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs impair platelet function, and their combination may increase bleeding risk. Dipyridamole has a weaker antiplatelet effect than many agents, but caution is warranted with caplacizumab.
How serious is the interaction between Caplacizumab and Dipyridamole?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding, and consider withholding dipyridamole if bleeding occurs during caplacizumab therapy.
What other medicines interact with Dipyridamole?
MediHelp also lists interactions of Dipyridamole with, for example, Riociguat, Adenosine, Betrixaban. The full list is on the Dipyridamole page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
